Breast Cancer Treatment Using the Magneto-Hyperthermia Technique Associated with Omega-3 Polyunsaturated Fatty Acids’ Supplementation and Physical Training

Author:

Theinel Matheus Haubert1ORCID,Nucci Mariana Penteado2ORCID,Cianciarullo Gabriela1ORCID,Oliveira Fernando Anselmo1ORCID,Alves Arielly da Hora1ORCID,Mamani Javier Bustamante1ORCID,Rego Gabriel Nery de Albuquerque1,Valle Nicole Mastandrea Ennes do1ORCID,Dias Olívia Furiama Metropolo1ORCID,Costa Cícero Júlio Silva1ORCID,Nascimento Felipe Lima1,Munoz Juan Matheus1ORCID,Moraes Andressa Arruda de1,Gamarra Lionel Fernel1ORCID

Affiliation:

1. Hospital Israelita Albert Einstein, São Paulo 05652-000, SP, Brazil

2. LIM44—Hospital das Clínicas da Faculdade Medicina da Universidade de São Paulo, São Paulo 05403-000, SP, Brazil

Abstract

Breast cancer (BC) presents a growing global concern, mainly for the female population of working age. Their pathophysiology shows challenges when attempting to ensure conventional treatment efficacy without adverse effects. This study aimed to evaluate the efficacy of magneto-hyperthermia (MHT) therapy associated with supplementation with omega-3 polyunsaturated fatty acid (w-3 PUFA) and engagement in physical training (PT) for the triple-negative BC (TNBC) model. First, we assessed the physicochemical properties of iron oxide nanoparticles (ION) in biological conditions, as well as their heating potential for MHT therapy. Then, a bioluminescence (BLI) evaluation of the best tumor growth conditions in the TNBC model (the quantity of implanted cells and time), as well as the efficacy of MHT therapy (5 consecutive days) associated with the previous administration of 8 weeks of w-3 PUFA and PT, was carried out. The results showed the good stability and potential of ION for MHT using 300 Gauss and 420 kHz. In the TNBC model, adequate tumor growth was observed after 14 days of 2 × 106 cells implantation by BLI. There was a delay in tumor growth in animals that received w-3 and PT and a significant decrease associated with MHT. This pioneering combination therapy approach (MHT, omega-3, and exercise) showed a positive effect on TNBC tumor reduction and demonstrated promise for pre-clinical and clinical studies in the future.

Funder

CNPq

FAPESP

SisNANO 2.0/MCTIC

National Institute of Science and Technology Complex Fluids

Amigos da Oncologia e Hematologia Einstein

Publisher

MDPI AG

Reference97 articles.

1. WHO (2024, January 24). Breast Cancer. Available online: https://www.who.int/news-room/fact-sheets/detail/breast-cancer.

2. Risk Factors and Preventions of Breast Cancer;Sun;Int. J. Biol. Sci.,2017

3. Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor immunity;Delort;Life Sci.,2015

4. Mechanisms of breast cancer metastasis;Nathanson;Clin. Exp. Metastasis,2022

5. Instituto Nacional de Câncer—INCA (2023, August 10). Conceito e Magnitude. Definição do Câncer de Mama e Dados de Incidência e Mortalidade no Brasil, Available online: https://www.gov.br/inca/pt-br/search?SearchableText=cancer%20de%20mama.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3